We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Tumor Cells Pass Themselves Off as Platelets To Evade Detection

Tumor Cells Pass Themselves Off as Platelets To Evade Detection

Tumor Cells Pass Themselves Off as Platelets To Evade Detection

Tumor Cells Pass Themselves Off as Platelets To Evade Detection

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Tumor Cells Pass Themselves Off as Platelets To Evade Detection"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

The Liquid Biopsy and Cancer Interception research group—part of the Biohealth Research Institute in Granada (ibs.GRANADA), in which researchers from the University of Granada (UGR) participate—has discovered that tumour cells pass themselves off as platelets to go undetected in the bloodstream.

This finding constitutes a paradigm shift in terms of how the metastatic process unfolds, and may contribute not only to a better understanding of the tumour process but also to the development of treatments for intercepting the process of tumour dissemination and, ultimately, the appearance of metastasis.

Metastasis is the leading cause of cancer-related death, due to the release of tumour cells from a primary tumour into the bloodstream, where they can travel to another organ and create a secondary tumour. These cells are known as Circulating Tumour Cells (CTCs) and, despite being known for their prognostic and predictive value as cancer biomarkers, little is known about their biology. CTCs are capable not only of detaching from the tumour mass but also of withstanding attacks from the immune system and colonising distant organs.

This team of scientists from ibs.GRANADA , the UGR, GENyO, and the ‘Virgen de las Nieves’ Teaching Hospital in Granada have demonstrated for the first time that platelets are capable of transferring biomolecules such as lipids, proteins, and ribonucleic acid to the CTCs, which helps them to go unnoticed in the bloodstream. In other words, tumour cells acquire part of the configuration of platelets to ‘trick’ the body into believing they are platelets, enabling them to take over other organs.

Therefore, this study reveals how platelets can phenotypically, genetically, and functionally modify tumour cells, indicating which ones could play a crucial role in metastasis by interacting with and modifying CTCs.

This research was led by Dr. María José Serrano, researcher on the ‘Nicolás Monardes’ programme at the GENyO Center and in the ‘Virgen de las Nieves’ Teaching Hospital. The study was the result of collaboration with Dr. Pedro Real of the UGR, renowned oncologist Dr. Christian Rolfo of the Center for Thoracic Oncology at the Tisch Cancer Institute, Mount Sinai, member of the external advisory committee of ibs.GRANADA, and Dr. Massimo Cristofanilli of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Reference: Rodriguez-Martinez A, Simon-Saez I, Perales S, et al. Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior. Theranostics. 2022;12(5):2150-2161. doi: 10.7150/thno.64252

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.